Home » Newsletters » BioWorld

BioWorld

Feb. 7, 2000

View Archived Issues

NeoRx Moves Skeletal Targeted Radiotherapy To Phase III Study

Genzyme Transgenics Raises $70M In Public Stock Offering

Other News To Note

Agouron, PPD In $30M Pact To Find Targets Against HIV

Lab Rats Treated With Switched Amino Acid Peptide Overcame Prostate Cancer Lung Metastasis

Biotech Could Be Affected By FASB Interest-Pooling Hearings

COR's Integrilin Succeeds In Coronary Intervention Study

Rigel Continues Run Of Filings As It Seeks $100M Through IPO

Antigenics' IPO Raises $63M To Fund Trials Of Oncophage

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...